Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 29 | ICEECE2012 | Next issue

15th International & 14th European Congress of Endocrinology

Poster Presentations

Adrenal cortex

Table of contents
Next section
Adrenal medulla

ea0029p1 | Adrenal cortex

Targeting mutated β-catenin in vitro and in vivo inhibits cell proliferation and stimulates apoptosis: a promising therapeutic target in adrenocortical carcinoma

ea0029p2 | Adrenal cortex

Pathophysiological significance of CYP11B2 immunohistochemical staining in primary aldosteronism

ea0029p3 | Adrenal cortex

The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in the diagnosis of subclinical hypercortisolism (SH) in patients with adrenal incidentaloma (AI).

ea0029p4 | Adrenal cortex

Semen parameters in men with congenital adrenal hyperplasia (CAH) due to 21-hydroxilase deficiency (21-HD)

ea0029p5 | Adrenal cortex

Non-radioactive strategies on the diagnosis of congenital adrenal hyperplasia due to 21 hydroxylase deficiency (CAH - 21OHD).

ea0029p6 | Adrenal cortex

Diagnostic value of urinary steroid profiling in the evaluation of adrenal incidentaloma.

ea0029p7 | Adrenal cortex

The combined use of nocturnal salivary cortisol and urinary cortisol to creatinine ratio in the evaluation of cycling in patients with Cushing’s syndrome

ea0029p8 | Adrenal cortex

Defining 17α-hydroxylase in zebrafish: expression pattern of two paralog genes (zCyp17a1; zCyp17a2) and comparative in vitro and in silico analysis

ea0029p9 | Adrenal cortex

Progressive adrenal insufficiency in a patient with 46,XY DSD caused by two novel mutations in the cytochrome P450 side-chain cleavage (CYP11A1) gene

ea0029p10 | Adrenal cortex

The mTOR-pathway in normal and tumoral human adrenocortical tissues

ea0029p11 | Adrenal cortex

Measurement of cortisol in scalp hair can be a new tool in the diagnosis and follow-up of patients with Addison’s Disease and (cyclic) Cushing’s Syndrome

ea0029p12 | Adrenal cortex

Pattern of adrenal hormonal secretion in patients with adrenal adenomas: the relevance of aldosterone in arterial hypertension

ea0029p13 | Adrenal cortex

Influence of unilateral adrenalectomy on set point of Hypothalamic-pituitary-adrenal-axis in long-term survivors of childhood nephroblastoma and neuroblastoma

ea0029p14 | Adrenal cortex

PET-tracers for differential diagnosis in primary hyperaldosteronism – in vitro studies

ea0029p15 | Adrenal cortex

Role of Endogenous Somatostatin and Cortistatin in Regulating Adrenal Gland Function

ea0029p16 | Adrenal cortex

Cyclical Cushing’s syndrome masquerading as Polycystic Ovarian Syndrome – pitfalls in diagnosis

ea0029p17 | Adrenal cortex

Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism following adrenalectomy

ea0029p18 | Adrenal cortex

Use of the 250 mcg short synacthen test in the diagnosis of primary aldosteronism

ea0029p19 | Adrenal cortex

Evaluation of sexual function and psychological attitudes in adult women with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase Deficiency (21-HD)

ea0029p20 | Adrenal cortex

Role of adrenal vein sampling in primary aldosteronism. Impact of different diagnostic criteria on subtype diagnosis

ea0029p21 | Adrenal cortex

Predicting factors of the post-surgical decline in renal function in patients with primary aldosteronism

ea0029p22 | Adrenal cortex

Specialized surgery for adrenocortical carcinoma in The Netherlands: analysis of national cancer registry data

ea0029p23 | Adrenal cortex

Long term follow-up of patients with adrenal incidentalomas – a prospective study

ea0029p24 | Adrenal cortex

Effects of sugar cane extract (SCE) supplementation on steroidogenesis of the adrenal cortex in male rats

ea0029p25 | Adrenal cortex

Evaluation of renal function of primary aldosteronism between pre- and post-treatment

ea0029p26 | Adrenal cortex

Follow-up of nonsurgical nonfunctioning adrenal adenomas at five years

ea0029p27 | Adrenal cortex

Importance of the genetic study in fertile women with nonclassical congenital adrenal hyperplasia

ea0029p28 | Adrenal cortex

Aldosterone-producing cells regenerated from mesenchymal stem cells

ea0029p29 | Adrenal cortex

The ACTH-independent macronodular adrenal hyperplasia gene hunt: from candidate genes to a pangenomic strategy

ea0029p30 | Adrenal cortex

Superselective adrenal venous sampling for intra-adrenal localization of aldosterone hypersecretion.

ea0029p31 | Adrenal cortex

Analysis of the glucocorticoid receptors polymorphism in patients with adrenal incidentaloma and patients with Cushing’s syndrome.

ea0029p32 | Adrenal cortex

KCNJ5 Mutations in European Families with Non-Glucocorticoid Remediable Familial Hyperaldosteronism

ea0029p33 | Adrenal cortex

Applicability of the guideline for the diagnosis of primary hyperaldosteronism in patients with hypertension in Japan (PHAS-J2): Prospective multi-center study of national hospital organization

ea0029p34 | Adrenal cortex

Copy number alterations and loss of heterozygosity in cortisol-secreting adrenocortical adenomas using SNP arrays: evidence of new candidate genes and pathways.

ea0029p35 | Adrenal cortex

Differential DNA methylation of the CYP11B1 and CYP11B2 genes in association with human adrenal zonation

ea0029p36 | Adrenal cortex

Super-selective ACTH-stimulated adrenal venous sampling can discriminate the main lesion from the normal tissue for doing partial adrenalectomy in unilateral aldosterone-producing adenoma

ea0029p37 | Adrenal cortex

Deletion of TASK3 K+ channels leads to hyperaldosteronism in neonatal mice

ea0029p38 | Adrenal cortex

Expression of kisspeptin and its receptor in aldosterone-producing adrenal adenomas

ea0029p39 | Adrenal cortex

Reduction of the 10-year probability of fracture predicted by FRAX® and bone mass recovery in patients with Cushing’s Syndrome after 24 months from cure of hypercortisolism

ea0029p40 | Adrenal cortex

The Wnt/Beta-catenin and Ras/Raf/MEK/ERK signaling pathways alterations in adrenocortical tumors

ea0029p41 | Adrenal cortex

Cancer induces adrenal and pituitary alterations during the development of cachexia-anorexia syndrome

ea0029p42 | Adrenal cortex

A revolution in the diagnosis of adrenal disorders: rapid multiplex quantitation of serum steroids by means of tandem mass spectrometry (MSMS)

ea0029p43 | Adrenal cortex

Outcome of 232 patients with monolateral adrenal incidentaloma from a single centre

ea0029p44 | Adrenal cortex

Female patients with primary aldosteronism are diagnosed earlier and have a better outcome

ea0029p45 | Adrenal cortex

Influencing factors on quality of life in patients with Addison’s disease

ea0029p46 | Adrenal cortex

Differential methylation signature in benign and malignant cortisol producing adrenocortical tumors

ea0029p47 | Adrenal cortex

18-Hydroxycorticosterone, 18-hydroxycortisol and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes.

ea0029p48 | Adrenal cortex

MicroRNA profiling of benign and malignant adrenocortical tumors reveals potential biomarkers of recurrence

ea0029p49 | Adrenal cortex

Prevalence and Characteristics of Familial Hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino - GENetic forms).

ea0029p50 | Adrenal cortex

Intercurrent Illness Dose Regimen in Adrenal Insufficiency with a Dual Release Hydrocortisone Formulation Derived from Population Pharmacokinetic Modelling

ea0029p51 | Adrenal cortex

Cornell product left ventricular hypertrophy in electrocardiogram in patients with primary aldosteronism

ea0029p52 | Adrenal cortex

Efficacy of long-term treatment with retinoic acid in patients with Cushing’s disease

ea0029p53 | Adrenal cortex

Relationship of current glucocorticoid dose with metabolic outcomes in CAH: analysis of the United Kingdom congenital adrenal hyperplasia adult study executive (CaHASE) cohort

ea0029p54 | Adrenal cortex

Frequency and causes of adrenal crises over life-time in patients with 21-hydroxylase deficiency

ea0029p55 | Adrenal cortex

Urinary cortisol metabolites in corticotroph and adrenal tumours

ea0029p56 | Adrenal cortex

Soundwave’s effect on hematic cortisol level: a pilot study

ea0029p57 | Adrenal cortex

Reevaluation of the 4 mg intravenous dexamethasone suppression test for differentiation of Cushing’s disease from pseudo-Cushing’s syndrome

ea0029p58 | Adrenal cortex

Treatment with mineralocorticoid receptor antagonists in ‘subclinical’ cases with adrenal adenomas and autonomous aldosterone secretion

ea0029p59 | Adrenal cortex

The effects of the acute administration of alprazolam, a benzodiazepine, in patients with subclinical Cushing’s syndrome

ea0029p60 | Adrenal cortex

Is isolated secondary adrenal insufficiency more frequent than autoimmune Addison’s disease?

ea0029p61 | Adrenal cortex

Dyslipidemia in patients with adrenal incidentaloma with and without subclinical hypercortisolism and diabetes mellitus.

ea0029p62 | Adrenal cortex

Prevalence of primary aldosteronism in Chinese patients with resistant hypertension

ea0029p63 | Adrenal cortex

Genetic, anthropometric and metabolic features of adult norwegian patients with 21-hydroxylase deficiency

ea0029p64 | Adrenal cortex

Relationship between plasma dexamethasone level and cortisol in the overnight dexamethasone suppression test

ea0029p65 | Adrenal cortex

Mechanisms of gastroprotective action of corticotropin-releasing factor (CRF): involvement of CRF receptor subtypes 1 and 2

ea0029p66 | Adrenal cortex

Comparison of salivary cortysol by chemiluminensce and mass spectometry in hypercortilosism

ea0029p67 | Adrenal cortex

Renin-angiotensin-aldosterone system and inflammation - new aspects of an old system: results from the study of health in pomerania

ea0029p68 | Adrenal cortex

MGMT expression in human adrenocortical carcinoma cell lines and tissues and effects of temozolomide on tumor cell growth.

ea0029p69 | Adrenal cortex

New quick cortisol assay during adrenal vein sampling in patients with primary aldosteronism

ea0029p70 | Adrenal cortex

Primary aldosteronism is very frequent in resistant hypertension and is associated to early renal vascular damage

ea0029p71 | Adrenal cortex

Enhanced small dense LDL-subfractions, triglycerides and chemerin as early metabolic alterations in young patients with classic CAH due to 21-hydroxylase deficiency

ea0029p72 | Adrenal cortex

ACTH and cortisol responses to the combined DEXA-CRH test in patients with adrenal incidentalomas

ea0029p73 | Adrenal cortex

Idiopathic primary hyperaldosteronism frequently undergoes spontaneous remission: frequence and predictors

ea0029p74 | Adrenal cortex

Anxiety and depressive symptoms in patients with primary aldosteronism in a longitudinal study

ea0029p75 | Adrenal cortex

Drug prescription pattern in patients with autoimmune addison’s disease in Sweden

ea0029p76 | Adrenal cortex

Dosing regimens for glucocorticoid replacement therapy - a worldwide patient survey

ea0029p77 | Adrenal cortex

Significance of ACTH stimulation test in the diagnosis of an aldosterone-producing adenoma

ea0029p78 | Adrenal cortex

An open, multi-centre, phase IIIB, long term follow-up study to assess the safety, tolerability and efficacy of once-daily oral dual-release hydrocortisone in patients with adrenal insufficiency

ea0029p79 | Adrenal cortex

Malignant adrenal incidentalomas: clinical analysis of 2300 patients with adrenal incidentalomas registered at a single endocrinological center

ea0029p80 | Adrenal cortex

RRM1 Gene expression affects metabolization and activity of mitotane in adrenocortical cancer cell lines.

ea0029p81 | Adrenal cortex

The routine application of the current clinical recommendations for adrenal incidentalomas the management is highly inefficient

ea0029p82 | Adrenal cortex

The Effect of Glucocorticoid Receptor Polymorphisms on the Sensitivity to Cortisol in Addison’s disease

ea0029p83 | Adrenal cortex

Impact of reference values and published thresholds on clinically relevant cut-offs

ea0029p84 | Adrenal cortex

Hormonal and metabolic features in patients with adrenal incidentalomas according to 1 mg overnight dexamethasone suppression test

ea0029p85 | Adrenal cortex

Therapy with steroidogenesis inhibitors in Cushing’s syndrome: a reappraisal

ea0029p86 | Adrenal cortex

Ectopic Cushings and Nocardia series

ea0029p87 | Adrenal cortex

Laparoscopic adrenalectomy for large adrenal tumors

ea0029p88 | Adrenal cortex

Adiponectin gene polymorphisms in primary aldosteronism and their relation to the metabolic syndrome

ea0029p89 | Adrenal cortex

Primary aldosteronism associated with subclinical Cushing syndrome

ea0029p90 | Adrenal cortex

Primary aldosteronism during 2007–2011 in Iceland

ea0029p91 | Adrenal cortex

Low SLC26A2 expression in adrenal cells is associated with high aldosterone output

ea0029p92 | Adrenal cortex

Three-dimensional contrast-enhanced sonography in the diagnosis of incidentally discovered asymptomatic adrenal masses

ea0029p93 | Adrenal cortex

Evaluation of uni- and bilateral adrenal incidentalomas with (131I) 6β-iodomethyl-norcholesterol scintigraphy.

ea0029p94 | Adrenal cortex

The confirmatory Tests of primary aldosteronism should be selected in each countries - the analysis of 83 patients in our hospital

ea0029p95 | Adrenal cortex

ACTH stimulation improves the sensitivity of aldosterone to rennin ratio (ARR) for detecting inappropriate aldosterone secretion

ea0029p96 | Adrenal cortex

Diagnostics of primary aldosteronism: is obligatory use of confirmatory tests justified?

ea0029p97 | Adrenal cortex

Diagnosis of Cushing’s syndrome by automatic face classification using frontal and side-view photographs

ea0029p98 | Adrenal cortex

Cushing disease remission is independent of size tumor. twenty years experience in surgical treatment a Mexican Center

ea0029p99 | Adrenal cortex

Cushing’s disease – limitations and boundaries

ea0029p100 | Adrenal cortex

Exogenous corticosteroids: guilty or innocent?

ea0029p101 | Adrenal cortex

Pediatric Cushing disease: case report

ea0029p102 | Adrenal cortex

Proteomic approach to human adrenocortical cancer biology

ea0029p103 | Adrenal cortex

GH deficiency in patients with hypoadrenalism

ea0029p104 | Adrenal cortex

The functional assessment and growth rates of adrenal incidentalomas: a single center experience

ea0029p105 | Adrenal cortex

Adrenal venous sampling: local experience in Asian population

ea0029p106 | Adrenal cortex

Comparison of four immunoassays for measurement of cortisol levels

ea0029p107 | Adrenal cortex

Tertiary adrenal insufficiency: case report

ea0029p108 | Adrenal cortex

A case of HIV presenting as primary adrenal lymphoma

ea0029p109 | Adrenal cortex

Ketoconazole in surgery preparation and follow-up of Cushing’s disease - our experience

ea0029p110 | Adrenal cortex

Utility of CGM for the determination of optimal glucocorticoid replacement method in patients with adrenal insufficiency

ea0029p111 | Adrenal cortex

A case of subclinical Cushing’s syndrome who developed pseudo-aldosteronism caused by green juice

ea0029p112 | Adrenal cortex

Adrenal masses as the first demonstration of non endocrine tumors metastatic disease

ea0029p113 | Adrenal cortex

Usefulness of FDG–PET for detecting primary aldosteronism in patient who have bilateral adrenal incidentaloma

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more